Oscar Health (OSCR) Common Equity (2020 - 2026)

Oscar Health (OSCR) has 7 years of Common Equity data on file, last reported at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 24.77% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 24.77% YoY), and the FY2025 full-year result was $977.6 million, up 33546.73% from the prior year.
• Common Equity for Q1 2026 stood at $1.7 billion, up from $977.6 million in the prior quarter.
• Across five years, Common Equity topped out at $1.7 billion in Q1 2026 and bottomed at -$2.8 billion in Q2 2025.
• The 5-year median for Common Equity is $931.8 million (2023), against an average of $417.0 million.
• Peak annual rise in Common Equity reached 66805650.0% in 2025, while the deepest fall reached 140218750.0% in 2025.
• A 5-year view of Common Equity shows it stood at -$2.6 billion in 2022, then soared by 130.93% to $806.1 million in 2023, then tumbled by 100.36% to -$2.9 million in 2024, then soared by 33546.73% to $977.6 million in 2025, then soared by 70.52% to $1.7 billion in 2026.
• The last three Common Equity figures came in at $1.7 billion (Q1 2026), $977.6 million (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison